Dose-adjusted (DA)-EPOCH-R with high-dose methotrexate for newly diagnosed CD5-positive diffuse large b-cell lymphoma (CD5+ DLBCL): Interim results from a phase II study

This article has no abstract
Epistemonikos ID: 89f2aa84e05af9ea5331ac9d06f1e7a75e1d5dde
First added on: Feb 08, 2025